Last week I had an interesting conversation with someone from my (previous) Continuous Glucose Monitor (CGM) supplier. They called initially to inform me that they needed a new script to supply me with Libre 3s for the next year. I wrote a text to my GP requesting they contact the supplier which they did. The supplier got back to me and informed me that I was NOT eligible to receive Libre3s via Medicare now because the FDA had not approved them for use by patients on dialysis, regardless of the type, hemo, or PD.
Seems that inaccurate results were being provided by the Libre3 CGMs. I can vouch for that. For at least 6 early mornings in a row last week I was awakened to a low glucose alarm while I felt fine and knew such NOT to be the case.
So now, at least, it’s back to the finger prick, method of yesterday to ascertain my glucose. And this is in the age of AI etc. It just doesn’t seem right.
Leave a Reply